CD95/Fas stoichiometry in future precision medicine

被引:0
|
作者
Sica, Mauricio [1 ]
Roussel, Murielle [2 ,3 ]
Legembre, Patrick [2 ]
机构
[1] Inst Balseiro UNCuyo, Bariloche Atom Ctr, CONICET, Dept Fis Med GAANS CNEA, Ave Bustillo 9500, San Carlos De Bariloche, Rio Negro, Argentina
[2] Univ Limoges, UMR CNRS 7276, INSERM U1262, CRIBL, 2 Rue Marcland, Limoges, France
[3] CHU Dupuytren, Clin Hematol & Cellular Therapy Dept, Limoges, France
关键词
OSTEOCLAST DIFFERENTIATION FACTOR; FAS LIGAND; SIGNALING PATHWAY; DECOY RECEPTOR; DEATH DOMAIN; TNF; COMPLEX; CELLS; OSTEOPROTEGERIN; IDENTIFICATION;
D O I
10.1038/s41418-025-01493-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD95, also known as Fas, belongs to the tumor necrosis factor (TNF) receptor superfamily. The main biological function of this receptor is to orchestrate and control the immune response since mutations in CD95 or deregulation of its downstream signaling pathways lead to auto-immunity and inflammation. Interestingly, more than twenty years ago, pioneer studies highlighted that like TNFR1, TRAILR1 or CD40, CD95 pre-associates at the plasma membrane in a ligand-independent fashion. This self-association occurs through a domain designated pre-ligand assembly domain or PLAD. Although the disruption of this pre-association prevents CD95 signaling, no drugs targeting this region have been generated because many questions remain on the stoichiometry and conformation of this receptor. Despite more than 40.000 publications, no crystal structure of CD95 alone or in combination with its ligand, CD95L, exists. Based on other TNFR members, we herein discuss the predicted conformation of CD95 at the plasma membrane and how these putative structures might account for the induction of the cell signaling pathways.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] CD95 is not functional in human erythrocytes
    Sagan, D.
    Jermnim, N.
    Tangvarasittichai, O.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2010, 32 (06) : E244 - E247
  • [32] CD95 promotes tumour growth
    Chen, Lina
    Park, Sun-Mi
    Tumanov, Alexei V.
    Hau, Annika
    Sawada, Kenjiro
    Feig, Christine
    Turner, Jerrold R.
    Fu, Yang-Xin
    Romero, Iris L.
    Lengyel, Ernst
    Peter, Marcus E.
    NATURE, 2010, 465 (7297) : 492 - 496
  • [33] Fas/CD95 Signaling Pathway in Damage-Associated Molecular Pattern (DAMP)-Sensing Receptors
    Galli, Gael
    Vacher, Pierre
    Ryffel, Bernhard
    Blanco, Patrick
    Legembre, Patrick
    CELLS, 2022, 11 (09)
  • [34] Enhanced contact allergen- and UVB-induced keratinocyte apoptosis in the absence of CD95/Fas/Apo-1
    Hedrych-Ozimina, A.
    Behrendt, K.
    Hao, Z.
    Pofahl, R.
    Ussath, D.
    Knaup, R.
    Krieg, T.
    Haase, I.
    CELL DEATH AND DIFFERENTIATION, 2011, 18 (01) : 155 - 163
  • [35] Expression of Fas (CD95) and Fas ligand on peripheral blood mononuclear cells in critical illness and association with multiorgan dysfunction severity and survival
    Papathanassoglou, EDE
    Moynihan, JA
    McDermott, MP
    Ackerman, MH
    CRITICAL CARE MEDICINE, 2001, 29 (04) : 709 - 718
  • [36] Characterizing the regulatory Fas (CD95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer
    Mondal, Tanmoy
    Gaur, Himanshu
    Wamba, Brice E. N.
    Michalak, Abby Grace
    Stout, Camryn
    Watson, Matthew R.
    Aleixo, Sophia L.
    Singh, Arjun
    Condello, Salvatore
    Faller, Roland
    Leiserowitz, Gary Scott
    Bhatnagar, Sanchita
    Tushir-Singh, Jogender
    CELL DEATH AND DIFFERENTIATION, 2023, 30 (11) : 2408 - 2431
  • [37] Acquired resistance to Fas/CD95 Ligation in u937 cells is associated with multiple molecular mechanisms
    Blomberg, Jeanette
    Ruuth, Kristina
    Santos, Daniel
    Lundgren, Erik
    ANTICANCER RESEARCH, 2008, 28 (2A) : 593 - 599
  • [38] Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: Therapeutic implications for hepatitis C
    Wederneyer, Inga
    Bechmann, Lars P.
    Odenthal, Margarethe
    Jochum, Christoph
    Marquitan, Guido
    Drebber, Uta
    Gerken, Guido
    Gleseler, Robert K.
    Dienes, Hans P.
    Canbay, Ali
    JOURNAL OF HEPATOLOGY, 2009, 50 (01) : 140 - 149
  • [39] CD95 Structure, Aggregation and Cell Signaling
    Levoin, Nicolas
    Jean, Mickael
    Legembre, Patrick
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [40] Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors - Implications for immune privilege and immune escape
    Bernstorff, WV
    Glickman, JN
    Odze, RD
    Farraye, FA
    Joo, HG
    Goedegebuure, PS
    Eberlein, TJ
    CANCER, 2002, 94 (10) : 2552 - 2560